71 related articles for article (PubMed ID: 28286162)
21. Ovarian cancer stem cells: still an elusive entity?
Lupia M; Cavallaro U
Mol Cancer; 2017 Mar; 16(1):64. PubMed ID: 28320418
[TBL] [Abstract][Full Text] [Related]
22. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
[TBL] [Abstract][Full Text] [Related]
23. Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.
Yang S; Chen L; Chan DW; Li QK; Zhang H
Clin Proteomics; 2017; 14():31. PubMed ID: 28814946
[TBL] [Abstract][Full Text] [Related]
24. Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status.
Jian H; Li W; Ma Z; Huang J; Feng J; Song Y; Gao B; Zhu H; Tao M; Bai C; Ma S; Pan H; Qin S; Hua D; Yu Y; Lu S
Sci Rep; 2017 Aug; 7(1):8483. PubMed ID: 28814805
[TBL] [Abstract][Full Text] [Related]
25. The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
Park KS; Yang H; Choi J; Seo S; Kim D; Lee CH; Jeon H; Kim SW; Lee DH
Cancer Lett; 2017 Oct; 406():47-53. PubMed ID: 28797845
[TBL] [Abstract][Full Text] [Related]
26. Expression signatures of HOX cluster genes in cervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7.
Saha SS; Chowdhury RR; Mondal NR; Roy S; Sengupta S
Oncotarget; 2017 May; 8(22):36591-36602. PubMed ID: 28402266
[TBL] [Abstract][Full Text] [Related]
27. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
28. Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1.
Amano Y; Kikuchi M; Sato S; Yokoyama S; Umehara T; Umezawa N; Higuchi T
Bioorg Med Chem; 2017 May; 25(9):2617-2624. PubMed ID: 28336409
[TBL] [Abstract][Full Text] [Related]
29. Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.
Qamra A; Xing M; Padmanabhan N; Kwok JJT; Zhang S; Xu C; Leong YS; Lee Lim AP; Tang Q; Ooi WF; Suling Lin J; Nandi T; Yao X; Ong X; Lee M; Tay ST; Keng ATL; Gondo Santoso E; Ng CCY; Ng A; Jusakul A; Smoot D; Ashktorab H; Rha SY; Yeoh KG; Peng Yong W; Chow PKH; Chan WH; Ong HS; Soo KC; Kim KM; Wong WK; Rozen SG; Teh BT; Kappei D; Lee J; Connolly J; Tan P
Cancer Discov; 2017 Jun; 7(6):630-651. PubMed ID: 28320776
[TBL] [Abstract][Full Text] [Related]
30. [The influence and mechanisms of lysine-specific demethylase 1 (LSD1) on invasion and metastasis of colon cancer cells].
Ding J; Zhang ZM; Dong Q; Mi R; Xu KS; Yang XF; Liao GQ
Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(10):743-748. PubMed ID: 28316154
[No Abstract] [Full Text] [Related]
31. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
[TBL] [Abstract][Full Text] [Related]
32. N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness.
Dong H; Zeng L; Chen W; Zhang Q; Wang F; Wu Y; Cui B; Qi J; Zhang X; Liu C; Deng J; Yu Y; Schmitt CA; Du J
Cell Death Discov; 2023 May; 9(1):149. PubMed ID: 37149646
[TBL] [Abstract][Full Text] [Related]
33. Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances.
Ma C; Hu K; Ullah I; Zheng QK; Zhang N; Sun ZG
Front Oncol; 2022; 12():729088. PubMed ID: 35433472
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors for the recurrence of surgically excised basal cell carcinomas: A retrospective clinical and immunopathological pilot study.
Vornicescu C; Șenilă SC; Bejinariu NI; Vesa ȘC; Boșca AB; Chirilă DN; Melincovici CS; Sorițău O; Mihu CM
Exp Ther Med; 2021 Nov; 22(5):1336. PubMed ID: 34630690
[TBL] [Abstract][Full Text] [Related]
35. Glioma-associated oncogene homolog 1 stimulates FOXP3 to promote non-small cell lung cancer stemness.
Qi H; Li W; Zhang J; Chen J; Peng J; Liu Y; Yang S; Du J; Long X; Ng CS; Li MY; Chen GG
Am J Transl Res; 2020; 12(5):1839-1850. PubMed ID: 32509180
[TBL] [Abstract][Full Text] [Related]
36. Gli1 regulates stemness characteristics in gastric adenocarcinoma.
Qi W; Yang Z; Feng Y; Li H; Che N; Liu L; Xuan Y
Diagn Pathol; 2020 May; 15(1):60. PubMed ID: 32430068
[TBL] [Abstract][Full Text] [Related]
37. Gli1, a potential cancer stem cell marker, is strongly associated with prognosis in prostate cancer.
Lv L; Yang Z; Ma T; Xuan Y
Int J Clin Exp Pathol; 2018; 11(10):4957-4966. PubMed ID: 31949572
[TBL] [Abstract][Full Text] [Related]
38. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma.
Wang D; Gao Y; Zhang Y; Wang L; Chen G
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160489
[TBL] [Abstract][Full Text] [Related]
39. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures.
Essid N; Chambard JC; Elgaaïed AB
Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250
[TBL] [Abstract][Full Text] [Related]
40. Role and inhibition of GLI1 protein in cancer.
Mastrangelo E; Milani M
Lung Cancer (Auckl); 2018; 9():35-43. PubMed ID: 29628779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
